Categories Earnings, Technology
Skyworks Solutions Q3 earnings, revenue miss Street view; stock falls
Semiconductor company Skyworks Solutions (NASDAQ: SWKS) reported lower earnings and revenues for the third quarter of 2019. The results also missed the Street view. The company’s stock lost about 5% during Wednesday’s extended trading session.
Earnings, on an adjusted basis, dropped to $1.35 per share in the third quarter from $1.64 per share last year and missed the estimates. Reported profit was $144 million or $0.83 per share, down from last year’s earnings of $287 million or $1.57 per share.
Dragging down the bottom-line, third-quarter revenues declined 14% annually to $767 million, which also fell short of analysts’ consensus estimate.
Liam Griffin, CEO of Skyworks, said, “The core fundamentals of our business remain strong despite current market volatility. Demand for advanced connectivity and the expansive nature of 5G are creating real-time opportunities for architectures that facilitate high-speed data, near-zero latency and exceptional reliability,”
Also see: Skyworks Solutions Q2 2019 Earnings Call Transcript
During the quarter, the company commenced volume production of its BAW-enabled Sky5 devices. The management, meanwhile, hiked the quarterly dividend by 16% to $0.44 per share. The dividend will be paid on September 17, 2019, to stockholders of record on August 27, 2019.
Looking ahead, the company said it is on track to deliver sequential revenue and earnings growth in the fourth quarter. Revenues are expected to be between $815 million and $835 million in the September quarter when adjusted earnings are expected to come in at $1.50 per share.
Also read: Booking Holdings reports better-than-expected Q2 results
Skyworks shares have declined 5% in the past twelve months. However, they regained momentum and rose 17% since the beginning of the year. The stock lost sharply during Wednesday’s extended trading after closing the regular session higher.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on